Company Profile

Apyx® Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion® and J-Plasma® in surgical markets. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.

COMPANY ADDRESS

Apyx Medical Corporation
5115 Ulmerton Road • Clearwater, FL 33760-4004 • USA
Ph +1 727 384 2323

MANAGEMENT TEAM

Charles D. Goodwin, President and Chief Executive Officer | Bio
Tara Semb, Chief Financial Officer | Bio
Moshe Citronowicz, Senior Vice President | Bio
Todd Hornsby, Executive Vice President | Bio

BOARD OF DIRECTORS

Andrew Makrides, Esq., Executive Chairman of the Board of Directors | Bio
Charles D. Goodwin, Chief Executive Officer & Director | Bio
John Andres, Director | Bio
Michael Geraghty, Director | Bio
Craig A. Swandal, Director | Bio
Lawrence J. Waldman, CPA, Director | Bio
Minnie Baylor-Henry, Director, Chair of Regulatory and Compliance Committee | Bio
Wendy Levine, Director | Bio

COMPANY INVESTOR PRESENTATION

SECOND QUARTER OF FISCAL YEAR 2023 FINANCIAL RESULTS

Management hosted a conference call at 5:00 p.m. Eastern Time on August 10th to discuss the results of the quarter. Click the button below to replay the webcast.

UPCOMING EVENTS

No events scheduled at this time.

RECENT EVENTS

Piper Sandler 34th Annual Healthcare Conference – 11/30/22

Lake Street Best Ideas Growth Conference – 9/14/22

The JMP Securities Life Sciences Conference. 6/16/22

The Craig-Hallum 19th Annual Institutional Investor Conference. 6/1/22

The Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum. 11/18/21

The Stifel 2021 Virtual Healthcare Conference. 11/17/21

The 12th Annual Craig-Hallum Alpha Select Conference. 11/16/21

2023 Proxy Materials

Corporate Governance